Dow Up 0.11% Nasdaq Up 0.50%

More On OPTR

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Optimer Pharmaceuticals, Inc. (OPTR)

-NasdaqGS
12.78 0.00(0.00%) Oct 23, 4:00PM EDT
Prev Close:12.78
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:14.00
Beta:0.14
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:8.64 - 16.80
Volume:0
Avg Vol (3m):1,433,510
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-1.75
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OPTR

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :N/A
Quarterly EPS Est (Sep-13) :N/A
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Optimer Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products in the United States and Canada. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback